743460-48-2,MFCD31731124
Catalog No.:AA00FH78

743460-48-2 | 1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
2 weeks  
$302.00   $211.00
- +
250mg
97%
2 weeks  
$633.00   $443.00
- +
1g
97%
2 weeks  
$1,929.00   $1,350.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00FH78
Chemical Name:
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
CAS Number:
743460-48-2
Molecular Formula:
C21H27N3O2
Molecular Weight:
353.4580
MDL Number:
MFCD31731124
SMILES:
CNCCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3
Properties

Downstream Synthesis Route

[1]Patent:US2004/167167,2004,A1.Locationinpatent:Page/Pagecolumn47

[2]Patent:US2005/113417,2005,A1.Locationinpatent:Page/Pagecolumn43-44

743460-48-2    619-66-9   
biphenyl-2-yl-carbamicacid1-{2-(4-formylbenzoyl)methylaminoethyl}piperidin-4-ylester 

[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2005/203133,2005,A1Locationinpatent:Page/Pagecolumn20

[2]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2006/205775,2006,A1Locationinpatent:Page/Pagecolumn20-21

[3]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2006/205779,2006,A1Locationinpatent:Page/Pagecolumn26

[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-WO2006/99165,2006,A1Locationinpatent:Page/Pagecolumn32-33

[2]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2005/203138,2005,A1Locationinpatent:Page/Pagecolumn20

[3]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2006/281740,2006,A1Locationinpatent:Page/Pagecolumn24

[4]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2012/16130,2012,A1Locationinpatent:Page/Pagecolumn11

[5]CurrentPatentAssignee:SHANGHAIGUSENPHARMACEUTICAL-CN112830890,2021,ALocationinpatent:Paragraph0073;0078-0079

[6]CurrentPatentAssignee:CIPLALTD-WO2022/49604,2022,A1Locationinpatent:Page/Pagecolumn10;35

[1]Patent:US2005/203137,2005,A1.Locationinpatent:Page/Pagecolumn20

[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2005/203133,2005,A1Locationinpatent:Page/Pagecolumn27

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Building Blocks
More >
Tags:743460-48-2 Molecular Formula|743460-48-2 MDL|743460-48-2 SMILES|743460-48-2 1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
Catalog No.: AA00FH78
743460-48-2,MFCD31731124
743460-48-2 | 1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
Pack Size: 100mg
Purity: 97%
2 weeks
$302.00 $211.00
Pack Size: 250mg
Purity: 97%
2 weeks
$633.00 $443.00
Pack Size: 1g
Purity: 97%
2 weeks
$1,929.00 $1,350.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00FH78
Chemical Name: 1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
CAS Number: 743460-48-2
Molecular Formula: C21H27N3O2
Molecular Weight: 353.4580
MDL Number: MFCD31731124
SMILES: CNCCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3
Properties
Downstream Synthesis Route
743460-48-2    85822-16-8    743461-19-0 

[1]Patent:US2004/167167,2004,A1.Locationinpatent:Page/Pagecolumn47

[2]Patent:US2005/113417,2005,A1.Locationinpatent:Page/Pagecolumn43-44

743460-48-2    619-66-9   
biphenyl-2-yl-carbamicacid1-{2-(4-formylbenzoyl)methylaminoethyl}piperidin-4-ylester 

[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2005/203133,2005,A1Locationinpatent:Page/Pagecolumn20

[2]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2006/205775,2006,A1Locationinpatent:Page/Pagecolumn20-21

[3]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2006/205779,2006,A1Locationinpatent:Page/Pagecolumn26

743460-48-2    619-66-9    864760-28-1 

[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-WO2006/99165,2006,A1Locationinpatent:Page/Pagecolumn32-33

[2]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2005/203138,2005,A1Locationinpatent:Page/Pagecolumn20

[3]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2006/281740,2006,A1Locationinpatent:Page/Pagecolumn24

[4]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2012/16130,2012,A1Locationinpatent:Page/Pagecolumn11

[5]CurrentPatentAssignee:SHANGHAIGUSENPHARMACEUTICAL-CN112830890,2021,ALocationinpatent:Paragraph0073;0078-0079

[6]CurrentPatentAssignee:CIPLALTD-WO2022/49604,2022,A1Locationinpatent:Page/Pagecolumn10;35

743460-48-2    627-91-8    864765-59-3 

[1]Patent:US2005/203137,2005,A1.Locationinpatent:Page/Pagecolumn20

743460-48-2    13731-82-3    864751-39-3 

[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2005/203133,2005,A1Locationinpatent:Page/Pagecolumn27

Building Blocks More >
Submit
© 2017 AA BLOCKS, INC. All rights reserved.